Cargando…

TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy

PURPOSE: To explore the value of Tuberous sclerosis complex 2 (TSC2) mutations in evaluating the early recurrence of hepatocellular carcinoma (HCC) patients underwent hepatectomy. PATIENTS AND METHODS: A total of 183 HCC patients were enrolled. Next-generation sequencing was performed on tumor tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Kangjian, He, Fu, Xin, Yang, Guan, Ge, Huo, Junyu, Zhu, Qingwei, Fan, Ning, Guo, Yuan, Zang, Yunjin, Wu, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896791/ https://www.ncbi.nlm.nih.gov/pubmed/33623416 http://dx.doi.org/10.2147/PGPM.S294307

Ejemplares similares

The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma
por: He, Fu, et al.
Publicado: (2021)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics
por: Zhang, Hui, et al.
Publicado: (2022)

TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
por: Ho, Daniel W H, et al.
Publicado: (2017)

Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center
por: Zhu, Qingwei, et al.
Publicado: (2023)

The outcome of the HCC patients underwent ALPPS: Retrospective study
por: Peng, Chihan, et al.
Publicado: (2019)

Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence
por: Yang, Jianming, et al.
Publicado: (2023)

Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
por: Tyburczy, Magdalena E., et al.
Publicado: (2015)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
por: Feng, Long-Hai, et al.
Publicado: (2023)

Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients
por: Jiangyi, Wang, et al.
Publicado: (2020)

Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy
por: Liu, Wanmin, et al.
Publicado: (2022)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2021)

Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
por: Rosengren, Thomas, et al.
Publicado: (2020)

Correction: Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2020)

The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
por: Hoogeveen-Westerveld, Marianne, et al.
Publicado: (2012)

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC
por: Chen, Bo, et al.
Publicado: (2021)

Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
por: Nellist, Mark, et al.
Publicado: (2015)

Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy
por: XU, Lining, et al.
Publicado: (2022)

Striatal Inhibition of MeCP2 or TSC1 Produces Sociability Deficits and Repetitive Behaviors
por: Lee, Yunjin, et al.
Publicado: (2018)

The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma
por: Xie, Gui-Lin, et al.
Publicado: (2023)

Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection
por: Liu, Guo-yan, et al.
Publicado: (2014)

Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece
por: Avgeris, Socratis, et al.
Publicado: (2017)

TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
por: Rosset, Clévia, et al.
Publicado: (2017)

Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Effects of Mutations in TSC Genes on Neurodevelopment and Synaptic Transmission
por: Bassetti, Davide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbk6br1iemlmide7rc7jja8jia